Join
Live feed
·
PRReleasevia Quantisnow
Cyclo Therapeutics Inc. logo

Cyclo Therapeutics Appoints Caroline Hastings, M.D. as Global Principal Investigator for Ongoing TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease

ByQuantisnow·Wall Street's wire, on your screen.
CYTH· Cyclo Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTH (Cyclo Therapeutics Inc.) and more on Quantisnow.